Blavatnik Len's Form 4 filing
Day One Biopharmaceuticals, Inc. (DAWN) · filed Jun 12, 2023
- Accession no.
- 0001209191-23-036242
- Filed
- Jun 12, 2023, 4:03 PM ET
- Trade date
- Jun 9, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $10.0M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blavatnik LenCIK 0001326628 | Other: Affiliate of 10% Owner |
| Access Industries Holdings LLCCIK 0001391297 | Other: Affiliate of 10% Owner |
| Access Industries Management, LLCCIK 0001508226 | Other: Affiliate of 10% Owner |
| AI Day1 LLCCIK 0001863302 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2023 | Common Stock | PPurchaseAcquired | +769,230 | $13.00 | +$9,999,990 | 11,453,868 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.